Georges Gemayel sold $1.0M of Supernus Pharmaceuticals (SUPN)

Executed Mar 5, disclosed Mar 9, 4 days later.

Value, as filed

$1.0M

18,787 sh across 2 lots

Executed

Mar 5

the trade date, as filed

Disclosed

Mar 9

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

GG Georges Gemayel Director profile →

Georges Gemayel (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in SUPN. The largest single filing was $1.0M of SUPN (18,787 sh across 2 lots, as filed), executed Mar 5.

The name

SUPN SUPN SUPN · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Georges Gemayel in SUPN

SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $392K
10,787 sh × $36.30
Exec Nov 8 2024
Filed Nov 12 2024 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $520K
14,213 sh × $36.62
Exec Nov 7 2024
Filed Nov 8 2024 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $435K
13,886 sh across 2 lots
Exec Sep 13 2024
Filed Sep 17 2024 · 5:30 PM ET